The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-19
DOI
10.3389/fimmu.2021.676181
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- VISTA: Coming of age as a multi‐lineage immune checkpoint
- (2020) M. A. ElTanbouly et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Structural insight into T cell coinhibition by PD-1H (VISTA)
- (2020) Benjamin T. Slater et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance
- (2020) Mohamed A. ElTanbouly et al. SCIENCE
- Prognostic value of VISTA in solid tumours: a systematic review and meta-analysis
- (2020) Xin-Lin He et al. Scientific Reports
- FOXD3 Regulates VISTA Expression in Melanoma
- (2020) Sheera R. Rosenbaum et al. Cell Reports
- Expression of the immune checkpoint VISTA in breast cancer
- (2020) Liju Zong et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets
- (2020) Diana Tronik-Le Roux et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer
- (2020) Reem Saleh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer
- (2020) Mara Kitsou et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy
- (2020) Xing Huang et al. Journal of Hematology & Oncology
- High VISTA Expression Correlates With a Favorable Prognosis in Patients With Colorectal Cancer
- (2020) Liju Zong et al. JOURNAL OF IMMUNOTHERAPY
- Immune checkpoints in tumor microenvironment and their relevance to the development of cancer stem cells
- (2020) Neda Khosravi et al. LIFE SCIENCES
- An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA
- (2020) Nishant Mehta et al. Scientific Reports
- The prognostic significance of VISTA and CD33-positive myeloid cells in cutaneous melanoma and their relationship with PD-1 expression
- (2020) Jae Won Choi et al. Scientific Reports
- VISTA Re-programs Macrophage Biology Through the Combined Regulation of Tolerance and Anti-inflammatory Pathways
- (2020) Mohamed A. ElTanbouly et al. Frontiers in Immunology
- Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer
- (2019) Jorge Blando et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The expression of the immune checkpoint regulator VISTA correlates with improved overall survival in pT1/2 tumor stages in esophageal adenocarcinoma
- (2019) Heike Loeser et al. OncoImmunology
- Immunotherapy in colorectal cancer: rationale, challenges and potential
- (2019) Karuna Ganesh et al. Nature Reviews Gastroenterology & Hepatology
- PD ‐L1, B7‐H3 and VISTA are highly expressed in gestational trophoblastic neoplasia
- (2019) Liju Zong et al. HISTOPATHOLOGY
- Combination of CTLA-4 and PD-1 blockers for treatment of cancer
- (2019) Anand Rotte JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Analysis of VISTA expression and function in renal cell carcinoma highlights VISTA as a potential target for immunotherapy
- (2019) Shanjuan Hong et al. Protein & Cell
- Immune checkpoint protein VISTA regulates antitumor immunity by controlling myeloid cell-mediated inflammation and immunosuppression
- (2019) Wenwen Xu et al. Cancer Immunology Research
- Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study
- (2019) Antonella Argentiero et al. Cancers
- Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer
- (2019) Apostolos Zaravinos et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Structure and Functional Binding Epitope of V-domain Ig Suppressor of T Cell Activation
- (2019) Nishant Mehta et al. Cell Reports
- VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
- (2019) Liju Zong et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Promising approaches in cancer immunotherapy
- (2019) Nima Taefehshokr et al. IMMUNOBIOLOGY
- VISTA is an acidic pH-selective ligand for PSGL-1
- (2019) Robert J. Johnston et al. NATURE
- PD-1H (VISTA)–mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus
- (2019) Xue Han et al. Science Translational Medicine
- VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma
- (2018) Ming Zhang et al. BMC CANCER
- VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival
- (2018) Lawrence F. Kuklinski et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- High-Density Infiltration of V-domain Immunoglobulin Suppressor of T-cell Activation Up-regulated Immune Cells in Human Pancreatic Cancer
- (2018) Jinʼe Liu et al. PANCREAS
- Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung
- (2018) Luka Brcic et al. VIRCHOWS ARCHIV
- Expression of V‑domain immunoglobulin suppressor of T cell activation is associated with the advanced stage and presence of lymph node metastasis in ovarian cancer
- (2018) Hong Liao et al. Oncology Letters
- VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML
- (2018) Liru Wang et al. OncoImmunology
- Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors
- (2018) Shan Xie et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- ErbB3 targeting enhances the effects of MEK inhibitor in wild-type BRAF/NRAS melanoma
- (2018) Claudia Capparelli et al. CANCER RESEARCH
- VSIG-3 as a ligand of VISTA inhibits human T cell function
- (2018) Jinghua Wang et al. IMMUNOLOGY
- Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
- (2018) Ming Yi et al. Molecular Cancer
- VISTA expressed in tumour cells regulates T cell function
- (2018) Kumuluzi Mulati et al. BRITISH JOURNAL OF CANCER
- VISTA expression by microglia decreases during inflammation and is differentially regulated in CNS diseases
- (2018) Malte Borggrewe et al. GLIA
- Immunoregulatory functions of VISTA
- (2017) Elizabeth C. Nowak et al. IMMUNOLOGICAL REVIEWS
- Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients
- (2017) Hojabr Kakavand et al. MODERN PATHOLOGY
- VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
- (2017) Jianjun Gao et al. NATURE MEDICINE
- The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?
- (2017) Christine Böger et al. OncoImmunology
- Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis
- (2017) Na Li et al. Scientific Reports
- FOXD3 Regulates Pluripotent Stem Cell Potential by Simultaneously Initiating and Repressing Enhancer Activity
- (2016) Raga Krishnakumar et al. Cell Stem Cell
- Impact of the physical microenvironment on tumor progression and metastasis
- (2016) Fabian Spill et al. CURRENT OPINION IN BIOTECHNOLOGY
- Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma
- (2016) Yuta Kondo et al. ORAL ONCOLOGY
- A New VISTA on combination therapy for negative checkpoint regulator blockade
- (2016) Jie Deng et al. Journal for ImmunoTherapy of Cancer
- Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation
- (2016) Patrícia Oliveira et al. Scientific Reports
- Fibroblast-derived Neuregulin 1 Promotes Compensatory ErbB3 Receptor Signaling in Mutant BRAF Melanoma
- (2015) Claudia Capparelli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses
- (2015) Jun Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Expression of the Novel Costimulatory Molecule B7-H5 in Pancreatic Cancer
- (2014) Joshua T. Byers et al. ANNALS OF SURGICAL ONCOLOGY
- VISTA Is an Immune Checkpoint Molecule for Human T Cells
- (2014) J. L. Lines et al. CANCER RESEARCH
- VISTA Regulates the Development of Protective Antitumor Immunity
- (2014) I. Le Mercier et al. CANCER RESEARCH
- Coinhibitory receptor PD-1H preferentially suppresses CD4+ T cell–mediated immunity
- (2014) Dallas B. Flies et al. JOURNAL OF CLINICAL INVESTIGATION
- Characterization of Programmed Death-1 Homologue-1 (PD-1H) Expression and Function in Normal and HIV Infected Individuals
- (2014) Preeti Bharaj et al. PLoS One
- Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity
- (2014) L. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-125b Regulates the Early Steps of ESC Differentiation through Dies1 in a TGF-Independent Manner
- (2013) Marica Battista et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Immunoglobulin Superfamily Protein Differentiation of Embryonic Stem Cells 1 (Dies1) Has a Regulatory Role in Preadipocyte to Adipocyte Conversion
- (2013) Gang Ren et al. PLoS One
- A regulatory loop involving Dies1 and miR-125a controls BMP4 signaling in mouse embryonic stem cells
- (2012) Silvia Parisi et al. FASEB JOURNAL
- Cancer Immunotherapy Comes of Age
- (2011) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
- (2011) Li Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutting Edge: A Monoclonal Antibody Specific for the Programmed Death-1 Homolog Prevents Graft-versus-Host Disease in Mouse Models
- (2011) D. B. Flies et al. JOURNAL OF IMMUNOLOGY
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search